Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.21 – $1.65
22% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 |
| Operating income | −$1.1M | −$574.4K | −$631.3K | −$5.5M |
| EBITDA | −$1.1M | −$574.2K | −$631.2K | −$5.8M |
| Net income | −$1.1M | −$598.6K | −$707.5K | −$6.2M |
| Net margin | — | — | — | — |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.32 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds KLTO.
No tracked institution reports a position in KLTO as of their last filing.
No one on the platform has traded KLTO yet.
| $38M |
| — |
| NRSNNeuroSense Therapeutics Ltd. | $0.71 | -6.27% | $18M | — |
| NRXSNeurAxis, Inc. | $7.14 | -1.79% | $88M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.